74 filings
8-K
VIR
Vir Biotechnology Inc
2 May 24
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2024 Financial Results
4:09pm
8-K
VIR
Vir Biotechnology Inc
18 Apr 24
Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy
8:44am
8-K
VIR
Vir Biotechnology Inc
22 Feb 24
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
4:12pm
8-K
VIR
Vir Biotechnology Inc
20 Feb 24
Departure of Directors or Certain Officers
4:33pm
8-K
VIR
Vir Biotechnology Inc
13 Dec 23
Cost Associated with Exit or Disposal Activities
4:06pm
8-K
07udccogzncmgunkkg9
3 Nov 23
Entry into a Material Definitive Agreement
4:37pm
8-K
2zp7ajfvmqtp987
2 Nov 23
Vir Biotechnology Provides Corporate Update and Reports Third Quarter 2023 Financial Results
4:09pm
8-K
s38r373a3d 8z
3 Oct 23
Entry into a Material Definitive Agreement
8:01am
8-K
gbbac
20 Sep 23
Departure of Directors or Certain Officers
6:02am
8-K
ro0qhq402q4n00hdu
3 Aug 23
Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2023 Financial Results
4:14pm
8-K
3ucvt9l
20 Jul 23
Vir Biotechnology Announces Topline Data from Phase 2 PENINSULA Trial Evaluating
8:04am
8-K
pskl39fcf0 4nje
23 May 23
Submission of Matters to a Vote of Security Holders
4:06pm
8-K
8cqxse zz
4 May 23
Vir Biotechnology Provides Corporate Update and Reports First Quarter 2023 Financial Results
4:16pm
8-K
ff7vmat6i
10 Mar 23
Regulation FD Disclosure
9:45pm
8-K
x9rl1jz1
8 Mar 23
Amendments to Articles of Incorporation or Bylaws
4:06pm
8-K
o3a7m7n68fuw0nr8
23 Feb 23
Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
4:05pm
8-K
ncc2gj23 su59
22 Feb 23
Other Events
8:41am
8-K
kk4c7cbd 3n
16 Feb 23
Departure of Directors or Certain Officers
8:36am
8-K
pwah0ak3hc5
13 Feb 23
Entry into a Material Definitive Agreement
4:31pm
8-K
i6ro6pea
25 Jan 23
Departure of Directors or Certain Officers
8:33am